×

Our Diagnostic Tests

Our Biopharma Services

Patients
- How We Help
  - We are dedicated to supporting you throughout your care journey by ensuring you have access to diagnostic testing to move forward with a personalized care plan.
- Diagnostic Solutions
  - Fighting disease is a complex and challenging experience. We are committed to swiftly providing the information you need so that you can get on the right care path as soon as possible.

Our Company
- Our Purpose
  - Our mission is to unite biopharma, physicians, and patients to transform the standard of care and improve outcomes with personalized diagnostics.
- - Our Team
  - Careers
  - Investor
  - Newsroom

Investors

Resources
- For Providers
- For Research
  - Ongoing Clinical Studies
- For Patients
  - Lung Nodule Patient Resources

Contact
- Patients
  - Please get in touch with our Customer Care team directly using our secure line (866)432-5930.
  Office Hours:
  - Monday - Friday
    7:00 AM Mountain Time – 5:30 PM Mountain Time

Careers
Order a Test

Investors
Careers
Physician Portal

Go Back

Canaccord Genuity 42nd Annual Growth Conference

Posted on 08/11/2022 by Biodesix

Aug 10, 2022 at 3:00 PM EDT

Watch the fireside chat now, featuring Scott Hutton, CEO of Biodesix
View webcast

Read more

Biodesix to Present at the 42nd Annual William Blair Growth Stock Conference

BOULDER, Colo.—(BUSINESS WIRE)— Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, ...

Learn more

Biodesix to Present at the Canaccord Genuity 42nd Annual Growth Conference

BOULDER, Colo.—(BUSINESS WIRE)—Aug. 3, 2022— Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung ...

Learn more

Biodesix to Participate in Two February Conferences

BOULDER, CO, February 12, 2021 – Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, ...

Learn more

The tests on this website have been developed and validated by Biodesix, Inc. and their performance characteristics have been reviewed and approved by the New York State Clinical Evaluation Program (NYS CLEP). They have not yet been cleared nor approved by the US Food and Drug Administration.

Subscribe to Our Newsletter

Our Tests
Our Services
Technologies
- Our Technologies
- Transparent AI Platform
Company
Contact

Privacy Policy & HIPAA
Terms & Conditions
GDPR Notice

©2024 Biodesix. All Rights Reserved